HIFU controls recurrent cancer in short run

External beam radiation doesn’t always eradicate prostate cancer. Researchers estimate that about 20% to 30% of patients experience a rising prostate-specific antigen (PSA), or biochemical recurrence of their disease, following treatment. Debate about what secondary, or salvage, treatment to try next has blossomed.

High-intensity focused ultrasound (HIFU), which uses sound waves to destroy cancerous tissue, is one option for treating a localized recurrence (see Figure 1 below). Because each pulse of energy ablates only a small amount of tissue, doctors can target certain areas and spare others, theoretically minimizing the chances of side effects.

Figure 1: High-intensity focused ultrasound (HIFU)

During HIFU, pulses of energy produced by a rectal probe destroy tissue at the point where sound waves converge. Because the technology can target certain areas and spare others, side effects may be minimized.

British researchers recently examined the effectiveness of HIFU in 31 men who experienced a biochemical recurrence of prostate cancer following external beam radiation. Prior to HIFU, the average PSA among the men was 7.7 ng/ml. Three months after HIFU, about 65% had a PSA of 0.2 ng/ml or less. Of those who reached the six- and nine-month check-ups, about half maintained a PSA at that level.

Side effects of HIFU included narrowing of the urethra and the need for a procedure to remove dead tissue, urinary tract infections, painful urination, urinary incontinence, and, rarely, the formation of a hole between the rectum and urethra. The chance of side effects was on a par with that of other salvage treatments, making HIFU a seemingly feasible option.

Choosing appropriate patients for salvage HIFU remains the biggest challenge, the researchers noted. HIFU will not effectively treat metastatic cancer, but some patients harbor cancer that has spread elsewhere in the body and evades detection prior to HIFU.

SOURCE: Zacharakis E, Ahmed HU, Ishaq A, et al. The Feasibility and Safety of High-Intensity Focused Ultrasound as Salvage Therapy for Recurrent Prostate Cancer Following External Beam Radiation Therapy. BJU International 2008;102:786–92. PMID: 18564135.

Originally published April 1, 2009; last reviewed March 31, 2011.


Hi I have been in hormone treatment for 3 years and the psa is always been low (0.9 or lower) but at the same time the side effects are taking a toll on me as lack of sleep high blood pressure. Hot flashes


Welcome comment regarding HIFU procedure on first diagnosis of prostate cancer, stage 1, 3.4 PSA abd 6 Gleason.


i feel much better after taking a herbal medicine called Diuretic and Anti-inflammatory Pill, which has no side effect. you can have a try.

Post a Comment

This blog aims to provide reliable information as well as healthy dialog about the topics covered. We reserve the right to remove comments for any reason, particularly those that do not relate directly to the contents of this post, are commercial in nature, contain objectionable or inappropriate material, or otherwise violate our Privacy Policy. Comments on this blog do not represent the views of our editors or Harvard University, and have not been checked for accuracy. All comments submitted to this site become the non-exclusive property of Harvard University.